Graphene-Polymer Bone Scaffolds for Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current clinical treatments for bone graft procedures, such as autografts and synthetic bone grafts, face limitations including limited supply, complications, and inadequate bone healing, particularly for larger bone defects.
Innovation Solution
Development of porous scaffolds composed of biodegradable polymer microspheres blended with graphene family materials, such as graphene oxide, which are mechanically robust and biologically active, allowing for effective bone tissue regeneration and replacement.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If synthetic bone grafts are used, then supply is sufficient and no donor site morbidity occurs, but bone healing enhancement and tissue regeneration are inadequate
Solution Approach 1:
The patent employs composite materials by combining biodegradable polymers (PLGA, PCL, chitosan) with graphene family materials (graphene oxide, reduced graphene oxide, functionalized derivatives). This composite structure provides both sufficient supply and enhanced bone healing capabilities, resolving the contradiction between quantity and reliability. The graphene components enhance mechanical strength and biological activity while the polymer matrix provides structural support and controlled degradation.
Solution Approach 2:
The patent utilizes porous scaffold structures with controlled porosity (30-80%) to enable cell infiltration, nutrient transport, and waste removal. The porous architecture combined with biodegradable polymers and graphene materials provides adequate supply while simultaneously enhancing bone regeneration through improved cell-matrix interactions and mechanical properties.
2Reliability
If biodegradable polymer scaffolds are used, then biocompatibility is improved, but mechanical competence is insufficient
Solution Approach 1:
The patent resolves the mechanical weakness of biodegradable polymers by creating composite materials with graphene family materials. The graphene components (GO, rGO, functionalized derivatives) provide exceptional mechanical strength and stiffness to the polymer matrix, enabling the scaffold to bear physiological loads while maintaining biocompatibility through the biodegradable polymer structure.
Solution Approach 2:
The patent applies local quality enhancement by incorporating graphene family materials at specific concentrations (0.1-10 wt%) and locations within the scaffold structure. This localized reinforcement provides mechanical competence where needed while preserving the biocompatible nature of the bulk polymer material.
3Reliability
If autografts are used, then bone regeneration is effective, but operation time increases and donor site morbidity occurs
Solution Approach 1:
The patent employs disposable biodegradable polymer scaffolds that are pre-fabricated with graphene enhancements. These single-use implants eliminate the need for secondary harvesting procedures, reducing operation time while providing effective bone regeneration through their controlled degradation and osteoinductive properties.
Solution Approach 2:
The patent applies preliminary action by pre-fabricating the biodegradable polymer scaffolds with integrated graphene family materials and potential growth factor loading before implantation. This pre-preparation eliminates the need for intraoperative processing and reduces surgical time while ensuring the scaffold is ready to immediately support bone regeneration.
4Strength
If graphene family materials are added to polymer microspheres, then mechanical properties are enhanced, but manufacturing complexity increases
Solution Approach 1:
The patent manages manufacturing complexity by controlling key parameters such as graphene concentration (0.1-10 wt%), microsphere size (100-1000 μm), and porosity (30-80%). By establishing specific parameter ranges, the patent enhances mechanical properties through graphene incorporation while maintaining manufacturability through standardized production protocols.
Data Source
AI summary
The disclosure provides porous scaffold that include a plurality of microspheres, where the microspheres include a biodegradable polymer blended with a graphene family material (GFM), micro spheres, and methods for making and using such scaffolds and microspheres.